{"id":36655,"date":"2026-02-11T06:52:48","date_gmt":"2026-02-11T06:52:48","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/otc-analgesics-market-mordor\/"},"modified":"2026-03-27T06:26:22","modified_gmt":"2026-03-26T21:26:22","slug":"otc-analgesics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/otc-analgesics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc77c\ubc18\uc758\uc57d\ud488 \uc9c4\ud1b5\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/otc-analgesics-market_1689084750754_Screenshot_2023-07-11_194148.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/otc-analgesics-market-size-image-1767705070405.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uad6d\uc18c \uc9c4\ud1b5\uc81c \uc218\uc694 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uace0\ub839 \uc778\uad6c \uc99d\uac00 \ubc0f \uadfc\uace8\uaca9\uacc4 \uc9c8\ud658 \ubd80\ub2f4<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc77c\ubc18\uc758\uc57d\ud488 \uc9c4\ud1b5\uc81c\uc758 \ube44\uc6a9 \ud6a8\uc728\uc131 \ubc0f \ud3b8\uc758\uc131<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc804\uc790\uc0c1\uac70\ub798 \ubc0f \uc628\ub77c\uc778 \uc57d\uad6d\uc758 \uae09\uc18d\ud55c \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.5 \ube44\uc624\ud53c\uc624\uc774\ub4dc \uc77c\ubc18\uc758\uc57d\ud488 \uc0ac\uc6a9\uc744 \uac00\uc18d\ud654\ud558\ub294 \uc624\ud53c\uc624\uc774\ub4dc \uac10\uc18c \uc774\ub2c8\uc154\ud2f0\ube0c<\/li>\n<li class=\"toc-level-3\">4.2.6 \ud601\uc2e0\uc801\uc778 \uacbd\ud53c \ubc0f \uc18d\uc6a9\uc131 \uc804\ub2ec \uae30\uc220<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc57d\ubb3c \ub0b4\uc131, \uc758\uc874\uc131, \uc624\uc6a9 \ubc0f \ub0a8\uc6a9 \uc704\ud5d8<\/li>\n<li class=\"toc-level-3\">4.3.2 \uac04\ub3c5\uc131 \ubc0f \uc704\uc7a5\uad00\/\uc2ec\ud608\uad00 \uc704\ud5d8<\/li>\n<li class=\"toc-level-3\">4.3.3 \ubcc0\ub3d9\uc131 \uc788\ub294 \uba58\ud1a8\/API \uac00\uaca9\uc73c\ub85c \uc778\ud55c \uc81c\uc870\uc5c5\uccb4 \ub9c8\uc9c4 \uc555\ubc15<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc18c\ube44 \uc9c0\ucd9c\uc744 \uc804\ud658\uc2dc\ud0a4\ub294 \uc0c8\ub85c\uc6b4 \ube44\uc57d\ubb3c \ud1b5\uc99d \uc7a5\uce58<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc57d\ubb3c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc544\uc138\ud2b8\uc544\ubbf8\ub178\ud39c<\/li>\n<li class=\"toc-level-3\">5.1.2 \ube44\uc2a4\ud14c\ub85c\uc774\ub4dc\uc131 \uc18c\uc5fc\uc9c4\ud1b5\uc81c (NSAIDs)<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc0b4\ub9ac\uc2e4\uc0b0\uc5fc<\/li>\n<li class=\"toc-level-3\">5.1.4 \uae30\ud0c0 \uc9c4\ud1b5\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc81c\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uacbd\uad6c \uc81c\ud615<\/li>\n<li class=\"toc-level-3\">5.2.2 \uad6d\uc18c \uc81c\ud615<\/li>\n<li class=\"toc-level-4\">5.2.2.1 \ud06c\ub9bc &amp; \uc824<\/li>\n<li class=\"toc-level-4\">5.2.2.2 \uc2a4\ud504\ub808\uc774 &amp; \ub864\uc628<\/li>\n<li class=\"toc-level-4\">5.2.2.3 \uacbd\ud53c \ud328\uce58<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc6a9\ud574\uc131 \/ \uc18d\uc6a9\uc131 \uc2a4\ud2b8\ub9bd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc18c\ub9e4 \uc57d\uad6d &amp; \ub4dc\ub7ed\uc2a4\ud1a0\uc5b4<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc628\ub77c\uc778 \uc57d\uad6d &amp; \uc804\uc790\uc0c1\uac70\ub798 \ud50c\ub7ab\ud3fc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.4.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Bayer AG<\/li>\n<li class=\"toc-level-3\">6.3.2 Boehringer Ingelheim International GmbH<\/li>\n<li class=\"toc-level-3\">6.3.3 Cipla Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.4 Dr. Reddy&#8217;s Laboratories Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.5 Endo International PLC<\/li>\n<li class=\"toc-level-3\">6.3.6 GlaxoSmithKline plc<\/li>\n<li class=\"toc-level-3\">6.3.7 Haleon PLC<\/li>\n<li class=\"toc-level-3\">6.3.8 Hisamitsu Pharmaceutical Co., Inc.<\/li>\n<li class=\"toc-level-3\">6.3.9 Johnson &amp; Johnson<\/li>\n<li class=\"toc-level-3\">6.3.10 Mankind Pharma Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.11 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.12 Perrigo Company plc<\/li>\n<li class=\"toc-level-3\">6.3.13 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 PGT Healthcare LLP<\/li>\n<li class=\"toc-level-3\">6.3.15 Reckitt Benckiser Group PLC<\/li>\n<li class=\"toc-level-3\">6.3.16 Sanofi SA<\/li>\n<li class=\"toc-level-3\">6.3.17 Sun Pharmaceutical Industries Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.18 Taisho Pharmaceutical Holdings Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.19 Teva Pharmaceutical Industries Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.20 Viatris Inc.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ube44\ucc98\ubc29(OTC) \uc9c4\ud1b5\uc81c \uc2dc\uc7a5\uc740 2026\ub144 313\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 379\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 3.87%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \ubcf8 \uc2dc\uc7a5 \ubcf4\uace0\uc11c\ub294 \uc758\uc57d\ud488 \uc720\ud615(\uc544\uc138\ud2b8\uc544\ubbf8\ub178\ud39c, \ube44\uc2a4\ud14c\ub85c\uc774\ub4dc\uc131 \uc18c\uc5fc\uc9c4\ud1b5\uc81c, \uc0b4\ub9ac\uc2e4\uc0b0\uc5fc \ub4f1), \uc81c\ud615(\uacbd\uad6c \uc81c\ud615 \ub4f1), \uc720\ud1b5 \ucc44\ub110(\ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \uc57d\uad6d \ubc0f \uc57d\uad6d \ub4f1) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc774\uba70, \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Haleon, Kenvue, Bayer, Reckitt, Sanofi \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \ub3d9\ud5a5<br \/>\n\uaddc\uc81c \ub2f9\uad6d\uc740 \ucc98\ubc29\uc57d\uc758 OTC \uc804\ud658\uc744 \uc2e0\uc18d\ud558\uac8c \ucd94\uc9c4\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc790\uac00 \uce58\ub8cc\ub97c \uac15\ud654\ud558\uace0 \uc751\uae09\uc2e4 \ubd80\ub2f4\uc744 \uc644\ud654\ud558\ub294 \ub370 \uae30\uc5ec\ud569\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc740 2024\ub144 12\uc6d4 ACNU \uacbd\ub85c\ub97c \ub3c4\uc785\ud558\uc5ec \ud2b9\uc815 \uc9c4\ud1b5\uc81c\uac00 \uc2e0\uc57d \uc2e0\uccad \uc808\ucc28 \uc5c6\uc774 OTC \uc9c0\uc704\ub97c \ud68d\ub4dd\ud560 \uc218 \uc788\ub3c4\ub85d \ud588\uc2b5\ub2c8\ub2e4. \ub3d9\uc2dc\uc5d0, \uc9c0\ubd88\uc790\ub4e4\uc740 \uc804\uc2e0 \uc704\ud5d8\uc744 \ub0ae\ucd94\uace0 \ubcf5\uc57d \uc21c\uc751\ub3c4\ub97c \ub192\uc774\ub294 \uad6d\uc18c \uc81c\ud615 \ubc0f \uc18d\uc6a9\uc131 \uc81c\ud615\uc744 \uc120\ud638\ud558\ub294 \uacbd\ud5a5\uc744 \ubcf4\uc785\ub2c8\ub2e4.<br \/>\n\uacf5\uae09 \uce21\uba74\uc5d0\uc11c\ub294 2025\ub144 \ucd08 \uc911\uad6d\uc758 \uc0dd\uc0b0\ub7c9 \uac10\ucd95 \uc774\ud6c4 \uc544\uc138\ud2b8\uc544\ubbf8\ub178\ud39c \uc6d0\ub8cc\uc758\uc57d\ud488(API) \uac00\uaca9\uc774 12% \uc0c1\uc2b9\ud558\uc5ec \uc81c\ub124\ub9ad \ubc0f \ube0c\ub79c\ub4dc \uc81c\ud488 \ubaa8\ub450\uc758 \ub9c8\uc9c4\uc5d0 \uc555\ubc15\uc744 \uac00\ud588\uc2b5\ub2c8\ub2e4. \uc720\ud1b5 \ucc44\ub110\uc5d0\uc11c\ub294 \uc5ec\uc804\ud788 \ubcd1\uc6d0 \uc57d\uad6d\uc774 \uc9c0\ubc30\uc801\uc774\uc9c0\ub9cc, \uc804\uc790 \uc57d\uad6d\uc758 \uae09\uc18d\ud55c \ud655\uc7a5\uacfc \ub2f9\uc77c \ubc30\uc1a1 \uc11c\ube44\uc2a4 \ub3c4\uc785\uc73c\ub85c \uc778\ud574 \ubcd1\uc6d0 \uc57d\uad6d\uc758 \ud3b8\uc758\uc131 \uc774\uc810\uc774 \uc57d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. Haleon \ubc0f Kenvue\uc640 \uac19\uc740 \uc18c\ube44\uc790 \uac74\uac15 \ubd80\ubb38 \ubd84\uc0ac \uae30\uc5c5\ub4e4\uacfc \uc800\ube44\uc6a9 \uc0dd\uc0b0 \ubc0f \uc9c1\uc811 \uc720\ud1b5\ub9dd\uc744 \ud65c\uc6a9\ud558\ub294 \uc9c0\uc5ed \uc81c\ub124\ub9ad \uae30\uc5c5\ub4e4 \uac04\uc758 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4&#8230;&#8230;.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ucc98\ubc29\uc804 \uc5c6\uc774 \uad6c\ub9e4 \uac00\ub2a5\ud55c \ud1b5\uc99d \uc644\ud654 \ubc0f \ud574\uc5f4\uc81c\uc778 \uc77c\ubc18\uc758\uc57d\ud488(OTC) \uc9c4\ud1b5\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uae00\ub85c\ubc8c OTC \uc9c4\ud1b5\uc81c \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 379\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2022\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 3.87%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uad6d\uc18c \uc9c4\ud1b5\uc81c \uc218\uc694 \uc99d\uac00, \uace0\ub839\ud654 \uc778\uad6c \ubc0f \uadfc\uace8\uaca9\uacc4 \uc9c8\ud658 \ubd80\ub2f4 \uc2ec\ud654, OTC \uc9c4\ud1b5\uc81c\uc758 \ube44\uc6a9 \ud6a8\uc728\uc131 \ubc0f \ud3b8\uc758\uc131, \uc804\uc790\uc0c1\uac70\ub798 \ubc0f \uc628\ub77c\uc778 \uc57d\uad6d\uc758 \uae09\uc18d\ud55c \ud655\uc7a5, \ube44(\u975e)\ub9c8\uc57d\uc131 OTC \uc9c4\ud1b5\uc81c \ucc44\ud0dd\uc744 \uac00\uc18d\ud654\ud558\ub294 \uc624\ud53c\uc624\uc774\ub4dc \uac10\uc18c \uc774\ub2c8\uc154\ud2f0\ube0c, \uadf8\ub9ac\uace0 \ud601\uc2e0\uc801\uc778 \uacbd\ud53c \ubc0f \uc18d\uc6a9\uc131 \uc804\ub2ec \uae30\uc220\uc758 \ubc1c\uc804 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \uc57d\ubb3c \ub0b4\uc131, \uc758\uc874\uc131, \uc624\uc6a9 \ubc0f \ub0a8\uc6a9 \uc704\ud5d8, \uac04\ub3c5\uc131 \ubc0f \uc704\uc7a5\/\uc2ec\ud608\uad00 \uc704\ud5d8, \uba58\ud1a8\/API \uac00\uaca9 \ubcc0\ub3d9\uc131\uc73c\ub85c \uc778\ud55c \uc81c\uc870\uc5c5\uccb4 \ub9c8\uc9c4 \uc555\ubc15, \uadf8\ub9ac\uace0 \ube44(\u975e)\uc81c\uc57d \ud1b5\uc99d \uc644\ud654 \uae30\uae30\uc758 \ub4f1\uc7a5\uc73c\ub85c \uc778\ud55c \uc18c\ube44\uc790 \uc9c0\ucd9c \ubd84\uc0b0 \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \uc57d\ubb3c \uc720\ud615, \uc81c\ud615, \uc720\ud1b5 \ucc44\ub110 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc57d\ubb3c \uc720\ud615\ubcc4\ub85c\ub294 \uc544\uc138\ud2b8\uc544\ubbf8\ub178\ud39c, \ube44\uc2a4\ud14c\ub85c\uc774\ub4dc\uc131 \uc18c\uc5fc\uc9c4\ud1b5\uc81c(NSAIDs), \uc0b4\ub9ac\uc2e4\uc0b0\uc5fc \ubc0f \uae30\ud0c0 \uc9c4\ud1b5\uc81c\uac00 \ud3ec\ud568\ub418\uba70, \ud2b9\ud788 \uc0b4\ub9ac\uc2e4\uc0b0\uc5fc\uc740 \uc2ec\ud608\uad00 \uc9c8\ud658 \uc608\ubc29 \ubc0f \uad6d\uc18c \ud1b5\uc99d \uc644\ud654\ub77c\ub294 \uc774\uc911 \ud3ec\uc9c0\uc154\ub2dd\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 6.06%\uc758 CAGR\ub85c \uc804\uccb4 \uc2dc\uc7a5 \uc131\uc7a5\ub960\uc744 \uc0c1\ud68c\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc81c\ud615\ubcc4\ub85c\ub294 \uacbd\uad6c \uc81c\ud615, \uad6d\uc18c \uc81c\ud615(\ud06c\ub9bc \ubc0f \uc824, \uc2a4\ud504\ub808\uc774 \ubc0f \ub864\uc628, \uacbd\ud53c \ud328\uce58), \uadf8\ub9ac\uace0 \uc18d\uc6a9\uc131\/\uc18d\ubd95\ud574 \uc2a4\ud2b8\ub9bd\uc73c\ub85c \ub098\ub269\ub2c8\ub2e4. \uad6d\uc18c \ud328\uce58, \uc824, \uc2a4\ud504\ub808\uc774\ub294 8.72%\uc758 CAGR\ub85c \uacbd\uad6c \uc81c\ud615\uc758 \uac70\uc758 \ub450 \ubc30\uc5d0 \ub2ec\ud558\ub294 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc138\ub97c \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc720\ud1b5 \ucc44\ub110\ubcc4\ub85c\ub294 \ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \uc57d\uad6d \ubc0f \ub4dc\ub7ed\uc2a4\ud1a0\uc5b4, \uc628\ub77c\uc778 \uc57d\uad6d \ubc0f \uc804\uc790\uc0c1\uac70\ub798 \ud50c\ub7ab\ud3fc\uc774 \uc788\uc73c\uba70, \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \uc804\uc790\uc57d\uad6d \ud5c8\uac00 \ubc0f \ub2f9\uc77c \ubc30\uc1a1 \uc11c\ube44\uc2a4\uc5d0 \ud798\uc785\uc5b4 9.79%\uc758 CAGR\ub85c \uae09\uc131\uc7a5\ud558\uba70 \ubcd1\uc6d0 \uc57d\uad6d\uc5d0 \uc801\uc751 \uc555\ub825\uc744 \uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \ubd84\uc11d\uc5d0\uc11c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub97c \ub2e4\ub8e8\uba70, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uaddc\uc81c \uc644\ud654, \uc804\uc790\uc0c1\uac70\ub798 \ud655\uc7a5, \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 7.53%\uc758 \ub192\uc740 \uc9c0\uc5ed CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Bayer AG, GlaxoSmithKline plc, Johnson &#038; Johnson, Sanofi SA \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc758 \uc0c1\uc138 \ud504\ub85c\ud544(\uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \ub610\ud55c, \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd, \ubbf8\uac1c\ucc99 \uc601\uc5ed \ubc0f \ucda9\uc871\ub418\uc9c0 \uc54a\uc740 \uc694\uad6c \uc0ac\ud56d\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-36655","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/36655"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=36655"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/36655\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=36655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=36655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=36655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}